Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components - PubMed (original) (raw)
Comparative Study
. 2003 Jan 1;170(1):508-19.
doi: 10.4049/jimmunol.170.1.508.
Affiliations
- PMID: 12496438
- DOI: 10.4049/jimmunol.170.1.508
Comparative Study
Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components
Marina A Dobrovolskaia et al. J Immunol. 2003.
Abstract
In this study, tolerance induction by preexposure of murine macrophages to Toll-like receptor (TLR)2 and TLR4 agonists was revisited, focusing on the major signaling components associated with NF-kappaB activation. Pretreatment of macrophages with a pure TLR4 agonist (protein-free Escherichia coli (Ec) LPS) or with TLR2 agonists (Porphyromonas gingivalis LPS or synthetic lipoprotein Pam3Cys) led to suppression of TNF-alpha secretion, IL-1R-associated kinase-1, and IkappaB kinase (IKK) kinase activities, c-jun N-terminal kinase, and extracellular signal-regulated kinase phosphorylation, and to suppression of NF-kappaB DNA binding and transactivation upon challenge with the same agonist (TLR4 or TLR2 "homotolerance," respectively). Despite inhibited NF-kappaB DNA binding, increased levels of nuclear NF-kappaB were detected in agonist-pretreated macrophages. For all the intermediate signaling elements, heterotolerance was weaker than TLR4 or TLR2 homotolerance with the exception of IKK kinase activity. IKK kinase activity was unperturbed in heterotolerance. TNF-alpha secretion was also suppressed in P. gingivalis LPS-pretreated, Ec LPS-challenged cells, but not vice versa, while Pam3Cys and Ec LPS did not induce a state of cross-tolerance at the level of TNF-alpha. Experiments designed to elucidate novel mechanisms of NF-kappaB inhibition in tolerized cells revealed the potential contribution of IkappaBepsilon and IkappaBxi inhibitory proteins and the necessity of TLR4 engagement for induction of tolerance to Toll receptor-IL-1R domain-containing adapter protein/MyD88-adapter-like-dependent gene expression. Collectively, these data demonstrate that induction of homotolerance affects a broader spectrum of signaling components than in heterotolerance, with selective modulation of specific elements within the NF-kappaB signaling pathway.
Similar articles
- Toll-like receptors; their physiological role and signal transduction system.
Takeuchi O, Akira S. Takeuchi O, et al. Int Immunopharmacol. 2001 Apr;1(4):625-35. doi: 10.1016/s1567-5769(01)00010-8. Int Immunopharmacol. 2001. PMID: 11357875 Review. - Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K, Fodor S, Mócsai A. Futosi K, et al. Int Immunopharmacol. 2013 Nov;17(3):638-50. doi: 10.1016/j.intimp.2013.06.034. Epub 2013 Aug 30. Int Immunopharmacol. 2013. PMID: 23994464 Free PMC article. Review.
Cited by
- Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.
Ainge GD, Martin WJ, Compton BJ, Hayman CM, Larsen DS, Yoon SI, Wilson IA, Harper JL, Painter GF. Ainge GD, et al. J Med Chem. 2011 Oct 27;54(20):7268-79. doi: 10.1021/jm2008419. Epub 2011 Oct 5. J Med Chem. 2011. PMID: 21936536 Free PMC article. - NF-κB1 inhibits NOD2-induced cytokine secretion through ATF3-dependent mechanisms.
Zheng S, Abraham C. Zheng S, et al. Mol Cell Biol. 2013 Dec;33(24):4857-71. doi: 10.1128/MCB.00797-13. Epub 2013 Oct 7. Mol Cell Biol. 2013. PMID: 24100018 Free PMC article. - Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.
Stark R, Choi H, Koch S, Lamb F, Sherwood E. Stark R, et al. Innate Immun. 2015 Aug;21(6):565-74. doi: 10.1177/1753425914564172. Epub 2014 Dec 24. Innate Immun. 2015. PMID: 25540284 Free PMC article. - Interaction of Hepatitis C virus proteins with pattern recognition receptors.
Imran M, Waheed Y, Manzoor S, Bilal M, Ashraf W, Ali M, Ashraf M. Imran M, et al. Virol J. 2012 Jun 22;9:126. doi: 10.1186/1743-422X-9-126. Virol J. 2012. PMID: 22726246 Free PMC article. Review. - The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.
Roberts ZJ, Goutagny N, Perera PY, Kato H, Kumar H, Kawai T, Akira S, Savan R, van Echo D, Fitzgerald KA, Young HA, Ching LM, Vogel SN. Roberts ZJ, et al. J Exp Med. 2007 Jul 9;204(7):1559-69. doi: 10.1084/jem.20061845. Epub 2007 Jun 11. J Exp Med. 2007. PMID: 17562815 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI-18797/AI/NIAID NIH HHS/United States
- AI-44936/AI/NIAID NIH HHS/United States
- DE-08182/DE/NIDCR NIH HHS/United States
- DE-09081/DE/NIDCR NIH HHS/United States
- DE14215/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous